Woodley BioReg Ltd

30/10/2023

Using the body’s immune system to fight cancer has been a long-standing goal.

The immune system is highly sophisticated and designed to detect subtle differences between cells and distinguish between “self” and “foreign”.

While still in its early days, researchers are looking to develop an “off-the-shelf" immunotherapy that can be used to treat a broad range of cancer patients.

This article is a refreshing rethink of an approach to treat cancer that’s often viewed as “an academic exercise”, but with the recent developments in vaccines and delivery systems, merits a further closer assessment of its potential.

Take a look: https://www.worldpharmanews.com/research/6431-can-immunity-from-routine-vaccines-be-used-to-fight-cancer

27/10/2023

It was a pleasure attending CPHI Barcelona this week, our team had a fantastic time connecting with people from all around the world.

We got the chance to learn more about the latest pharmaceutical landscape trends, attend various insightful sessions and chat with so many people in the industry.

Big thank you to CPHI for another great event – we’re already looking forward to the next one!

26/10/2023

Alzheimer’s Disease continues to be one of the most devastating diseases with limited treatments for those diagnosed with this condition.

Researchers continue to seek insights into how to slow the progression and ultimately prevent this disease.

Using mesenchymal stroma cells from bone marrow, researchers have developed a treatment (Lomecel-B) and conducted a Phase IIb study demonstrating the slowing of disease progression in patients with a mild form of the disease.

Read more here: https://www.europeanpharmaceuticalreview.com/news/187377/stem-cell-therapy-delivers-potential-in-alzheimers/

Top-line Phase IIa data has shown an allogeneic stem-cell therapy enabled a lack of deterioration in cognitive signals in mild Alzheimer’s.

25/10/2023

We’re currently in Barcelona attending CPHI! ✈️

Yesterday was a busy day of connecting with fellow pharma professionals, meetings and attending various learning sessions.

Drop us an email at enquiry@woodleybioreg.com if you’d like to arrange a meeting tomorrow. 🤝

24/10/2023

Did you know cannabis contains over 100 cannabinoids?

These are the naturally active constituents of the cannabis plant that bind to receptors throughout the body to produce a broad range of effects.

Because formal clinical trials in humans have not been performed to determine the benefits and risks the THC containing cannabis is not authorised as a medicine.

Whilst cannabinoids derived from the cannabis plant or synthetic cannabinoids are used widely as healthcare / OTC products, many other THC-containing products are not authorised as medicines, and are under scientific/clinical investigation for the treatment of a number of medical conditions.

🔗 Learn about the medical applications of cannabis: https://woodleybioreg.com/the-medical-applications-of-cannabis/

23/10/2023

Antibiotic resistance is a growing global concern, endangering the effectiveness of life-saving drugs.

The UK is facing this challenge head-on with innovative solutions, here’s how:

🌐 The World Health Organisation
World Health Organization (WHO) is at the forefront of the battle, offering guidance, expertise, and global coordination. They promote responsible antibiotic use, monitor resistance, and drive research and innovation.

🔬 UK's pioneering efforts
• TARGET Programme: Reducing unnecessary antibiotic prescriptions.
• Antibiotic Guardian Campaign: Empowering you to protect antibiotics.
• GARDP AMR Accelerator: Developing new antibiotics.
• STAR Programme: Optimising antibiotic use in specialized settings.

Take a look at the innovative studies and pilot schemes here: https://woodleybioreg.com/combating-antibiotic-resistance-pioneering-efforts-in-the-uk/

16/10/2023

Next week we’re attending CPHI Barcelona! 🤝

Staying updated with innovation and trends is vital in the ever-changing pharmaceutical industry.

Which is why events like CPHI are invaluable for industry professionals.

We're looking forward to networking, attending more insightful sessions, and discussing the latest pharmaceutical landscape trends.

If you're attending get in touch if you’d like to arrange a meeting.
📧 enquiry@woodleybioreg.com

13/10/2023

Despite our lack of understanding of the mode of action of cannabis, published research has highlighted its impact on conditions ranging from Type 2 diabetes to autism and skin disorders.

The use of medicinal cannabis to treat currently poorly managed conditions will continue to be debated, whilst targeted clinical studies are in progress for other conditions deemed more commercially viable.

Read about the latest cannabis research here: https://cannabishealthnews.co.uk/2023/09/21/new-cannabis-research-cancer-type-2-diabetes-autism-fibromyalgia-and-skin-disorders/

New research suggests cannabis may reduce risk of type 2 diabetes, other studies shed light on fibromyalgia, autism and skin disorders.

11/10/2023

Va**ng has reached record levels in the UK, especially among teens and young adults. But what do we really know about it’s impact on our lungs...

Let's take a closer look!

🫁 Clinical insights: Va**ng may be less harmful than traditional ci******es, but it's not risk-free.

Studies have shown that exposure to va**ng aerosols can lead to irritation of the respiratory tract, potentially resulting in symptoms such as coughing, wheezing, and shortness of breath.

💨 Va**ng-related lung injuries: In recent years, there has been an emergence of va**ng-related lung injuries (VALI), characterised by a spectrum of respiratory symptoms ranging from a mild cough to severe respiratory distress.

🚭 Smoking cessation: V**e pens came as a potential saviour for smokers and studies suggest that they can help individuals quit or reduce smoking. However, the long-term effects are unknown and continued research is essential.

Check out our comprehensive analysis on the health impacts of va**ng here: https://woodleybioreg.com/va**ng-in-the-uk-a-comprehensive-analysis/

**ng

The prevalence of va**ng has increased significantly yet relatively little is known about the potential effects of chronic va**ng on the respiratory system.

06/10/2023

The UK Government is funding a multi-agency initiative to expedite patient access to innovative technologies.

As well as supporting the rapid development and approval of new technologies, the IDAP initiative is also intended to provide rapid access to NHS patients.

Find out more here: https://www.gov.uk/government/news/uk-patients-set-to-have-faster-access-to-innovative-medical-technologies-via-new-pathway

The Innovative Devices Access Pathway (IDAP) pilot was launched today by the Department of Health and Social Care (DHSC), Health Technology Wales (HTW), the Medicines and Healthcare products Regulatory Agency (MHRA), the National Health Service England (NHSE), the National Institute for Health and C...

04/10/2023

Check out our Principal Consultant in a recent instalment of Insider Media's Q&A series on the Northern Powerhouse. 📣

Ash discusses what the initiative means to him, the need for more measurable benefits, and why collaboration between areas should be encouraged instead of competition.

Click here to read: https://www.insidermedia.com/news/national/powerhouse-perspective-dr-ash-ramzan

In the latest instalment of Insider's Q&A series on the Northern Powerhouse, Dr Ash Ramzan, founder of Woodley BioReg, discusses what the initiative means to him, the need for more…

03/10/2023

Before any new products hit the market or undergo clinical trials, they must go through a rigorous registration process with regulatory agencies and health boards.

This process is essential to ensure safety and effectiveness.

Click here to find out everything you need to know: https://woodleybioreg.com/resource/new-product-registrations/

02/10/2023

Medical cannabis was legalised in the UK five years ago, but the government hasn't really lifted the barriers for doctors prescribing whole-plant or raw cannabis on the NHS.

Our principal consultant Dr Ash Ramzan has client meetings in Lisbon this week where the climate is perfect for cannabis crop agriculture, making Portugal one of the leading producers of high-quality cannabis in Europe.

Because of this, the medicinal cannabis industry is more matured and better supported with analytical testing capabilities; something the UK industry lacks.

Woodley BioReg partners with organisations seeking regulation and licence counsel to cover both cultivation and possession of medicinal cannabis, and remain at the forefront of regulatory advice and guidance.

Please get in touch if we can assist with your regulatory and compliance requirements.

29/09/2023

Less than a month to go until CPHI Barcelona!

We’re really looking forward to participating in this year’s conference and exhibition.

It's the perfect opportunity to immerse ourselves in the latest innovations and trends in the pharmaceutical industry.

As well as a great opportunity for us to meet our clients and colleagues from around the world in one place.

We’re excited to network and learn from the best in the field.

Get in touch if you’d like to arrange a meeting.

https://woodleybioreg.com/attending-cphi-barcelona-2023/

Woodley BioReg looks forward to attending the upcoming CPHI Barcelona 2023, 24th-26th October.

27/09/2023

We’re currently in Suzhou attending China BioMed Innovation and Investment Conference! ✈️

The past two days have been jam-packed with discussions and networking.

It’s been great to work with the UK Embassy staff and Department of Business and Trade and meet Chinese companies with existing and new products destined for UK licensure.

With over 10 individual meetings and numerous discussions around the options to support UK product registrations, we’re looking forward to starting to support our Chinese colleagues and returning to meet those we were not able to during this trip.

25/09/2023

We’ve always known and are often reminded that taking exercise is good for both body and mind.

Now researchers have found that Irisin, a muscle-derived hormone, is present at reduced levels in people with Alzheimer’s.

There’s growing evidence that exercise can reduce amyloid beta deposits through the presence of Irisin.

Click the link below to find out more:
https://www.medicalnewstoday.com/articles/alzheimers-exercise-induced-hormone-may-help-reduce-plaque-and-tangles-in-the-brain

Researchers say a hormone known as irisin may be enhanced by exercise and can help with plaques and tangles that develop in the brain of people with Alzheimer's disease

22/09/2023

Next week our Principal Consultant is heading to China’s biggest conference in to present at the event!

We’ll be in for the 2023 BioMed Innovation and Investment Conference.

We’re honoured to have been invited by the Department for Business and Trade.

21/09/2023

Today is . Did you know that the number of people living with dementia is expected to triple by 2050?

Take a look at the changes you can make to reduce your risk of 👇
https://www.alzint.org/about/risk-factors-risk-reduction/
Alzheimer's Disease International

What are the risk factors for dementia and how can the risk be reduced?